SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: quidditch who wrote (2201)3/31/1999 10:59:00 AM
From: Don Miller  Read Replies (2) of 10280
 
I am not sure we are talking about the same Zacks, not Saks. I am a 30 day trial user. I have not received a correction as of this AM, and the last update was about 2300 hour yesterday showing a rating of 4, so I believe what I reported is current.

This is the Zacks I am referring to: wwwo.zacks.com

However I do see a brief mention of adjusting eps estimates as follows:
"ESTIMATE REVISIONS:
SEPR: VOLPE BROWN WHE decreased estimate for fiscal year
ending 12/99 from $-1.75 to $-3.32 on 03/29/99
SEPR: VOLPE BROWN WHE decreased estimate for quarter ending
03/99 from $-0.20 to $-0.83 on 03/29/99
SEPR: VOLPE BROWN WHE decreased estimate for quarter ending
06/99 from $-0.16 to $-0.72 on 03/29/99
SEPR: VOLPE BROWN WHE decreased estimate for quarter ending
09/99 from $-0.14 to $-0.93 on 03/29/99
SEPR: VOLPE BROWN WHE decreased estimate for quarter ending
12/99 from $-0.10 to $-0.85 on 03/29/99 "

It seems Zacks may finally have a firm grasp on the 1998 performance, IMHO.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext